Establishment, Hybridization, Dispersal, Impact, and Decline of Diorhabda spp. (Coleoptera: Chrysomelidae) Released for Biological Control of Tamarisk in Texas and New Mexico.

Three Diorhabda spp. tamarisk beetles (Coleoptera: Chrysomelidae) were established in Texas from 2003 to 2010 for biological control of tamarisk (Tamarix spp.): Mediterranean tamarisk beetles, D.

Overwintering survival, phenology, voltinism, and reproduction among different populations of the leaf beetle Diorhabda elongata (Coleoptera: Chrysomelidae).

The classical biological control program for exotic saltcedars (various Tamarix species and hybrids) has involved the assessment of different populations of the leaf beetle Diorhabda elongata (Brullé) s.l. that are promising for release in areas of North America that are located south of 37 degrees N latitude.

Biological control of weeds: research by the United States Department of Agriculture-Agricultural Research Service: selected case studies.

Research by the USDA-Agricultural Research Service (ARS) on biological control of weeds has been practiced for many years because of its inherent ecological and economic advantages. Today, it is further driven by ARS adherence to Presidential Executive Order 13112 (3 February 1999) on invasive species and to USDA-ARS policy toward developing technology in support of sustainable agriculture with reduced dependence on non-renewable petrochemical resources. This paper reports examples or case studies selected to demonstrate the traditional or classical approach for biological control programs using Old World arthropods against Tamarix spp, Melaleuca quinquenervia (Cav) ST Blake and Galium spurium L/G aparine L, and the augmentative approach with a native plant pathogen against Pueraria lobata Ohwi = P montana.

Chronic sodium valproate treatment in the rat: toxicity versus protection against seizures induced by indoklon.

A model for chronic treatment of rats with sodium valproate has been developed balancing efficacy, toxicity and dose control. The dose (300 mg/kg) and frequency (every 8 h) selected were somewhat toxic as measured by weight gain and failed to provide continuous protection against Indoklon induced seizures but yielded plasma valproate levels near the range of therapeutic human levels. Chronic treatment of rats at this dose and frequency yielded a significant negative correlation between weight gain and length of treatment as well as a significant negative correlation between plasma valproate concentration and length of treatment.